![]() |
市場調查報告書
商品編碼
1819879
2025-2033年獸醫傳染病診斷市場報告(依技術、動物類型、感染類型、最終用戶和地區)Veterinary Infectious Disease Diagnostics Market Report by Technology, Animal Type, Infection Type, End User, and Region 2025-2033 |
2024年,全球獸醫傳染病診斷市場規模達22億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到41億美元,2025-2033年期間的複合年成長率(CAGR)為7.2%。寵物和牲畜疾病盛行率的上升、寵物主人意識的提升、技術進步的迅速發展、對精準診斷的需求、先進工具的採用、寵物健康問題的日益關注、獸醫基礎設施的不斷擴展、政府在人畜共患疾病預防方面的舉措以及研究資金的增加,都是推動市場成長的因素。
寵物和牲畜傳染病的盛行率不斷上升
寵物和牲畜中傳染病的日益普及正在加速市場成長。例如,貓白血病病毒 (FeLV) 是貓中最常見的傳染病之一,影響美國和加拿大 2-3% 的貓科動物。寵物與人之間互動的增加進一步加劇了疾病傳播的風險。此外,快速的城市化、畜牧業模式的改變以及確診患者數量的增加也推動了市場的成長。推動獸醫傳染病診斷市場價值成長的另一個因素是,對準確及時的診斷方法的需求日益成長,這有助於有效控制和遏制這些疾病。
提高寵物主人的意識
寵物主人對早期疾病檢測重要性的認知不斷提高,是推動市場成長的關鍵因素。隨著寵物被視為家庭不可或缺的成員,主人越來越重視它們的健康和福祉。這種認知的提高導致對定期健康檢查、預防措施和早期診斷測試的需求日益成長。此外,先進診斷工具和技術的普及使寵物主人更容易獲得高品質的獸醫護理,進一步推動了對傳染病診斷的需求。
技術進步
根據市場概況,由於技術的快速進步,獸醫傳染病診斷的需求正在大幅成長。診斷技術的進步極大地提高了診斷效率和結果準確性,進一步推動了市場的成長。此外,旨在提高動物傳染病檢測和鑑定能力的聚合酶鍊式反應 (PCR) 等分子診斷技術的引入,也促進了市場的成長。此外,自動化分析儀和遠距醫療平台等數位醫療工具的引入簡化了診斷流程,也進一步支持了市場的成長。
免疫診斷佔大部分市場佔有率
根據獸醫傳染病診斷市場研究報告,由於對精準疾病檢測的需求不斷成長,免疫診斷領域佔據了最大的市場佔有率。免疫診斷測試,包括酵素連結免疫吸附試驗 (ELISA) 和免疫螢光試驗 (IFA),因其能夠特異性檢測與傳染病相關的抗體或抗原而至關重要。這種精確度對於識別病原體和早期診斷疾病至關重要,這對於有效的治療和疾病管理至關重要。隨著獸醫護理日益複雜,人們對能夠快速提供明確結果的高度可靠的診斷工具的期望也日益成長。寵物和牲畜傳染病的不斷蔓延,也加劇了對此類精準診斷解決方案的需求。
伴侶動物佔據該產業最大佔有率
獸醫傳染病診斷市場中的伴侶動物細分市場的發展得益於人們對寵物健康和福祉的關注,以及診斷技術的進步。此外,寵物主人越來越重視早期疾病檢測,他們更加意識到主動健康管理的益處,這也推動了市場的成長。這種意識的增強導致對能夠在疾病惡化之前發現疾病的診斷服務的需求不斷成長,從而改善寵物的健康狀況。該細分市場也受到先進診斷工具的推動,例如分子檢測和快速即時檢測,這些工具能夠提供準確及時的診斷結果。這些創新使獸醫能夠更有效地診斷和治療感染,從而提高伴侶動物的整體護理品質。
細菌感染是主要的細分市場
獸醫傳染病診斷市場中的細菌感染細分市場受動物細菌性疾病日益流行的推動,這需要先進的診斷工具來實現有效的管理和控制。寵物和牲畜中鉤端螺旋體病、結核病和沙門氏菌等細菌感染的發生率不斷上升,催生了對精準診斷解決方案的需求。人們日益意識到細菌性疾病對動物健康和生產力的影響,這也推動了對可靠診斷方法的需求,以確保早期發現和介入。此外,由於牲畜細菌感染可能導致食品供應污染,對食品安全關注度的轉變也推動了該細分市場的發展,這促使對檢測和監控提出了更嚴格的要求。獸醫保健基礎設施和服務的擴展,尤其是在新興經濟體,透過提高診斷技術的可近性,支持了該細分市場的成長。
參考實驗室佔據市場主導地位
獸醫傳染病診斷市場中參考實驗室細分市場的發展受到診斷檢測需求日益複雜化的驅動。隨著獸醫診斷技術日益複雜,參考實驗室因其先進的檢測能力和專業知識而日益受到重視。市場對能夠區分各種病原體和疾病的精確、全面的診斷檢測的需求日益成長,這推動了該細分市場的發展。這種複雜性要求使用高度專業化的設備和熟練的人員,而這正是參考實驗室的標誌。此外,該細分市場受益於需要進行全面、高解析度分析的診斷樣本數量的不斷成長,這進一步凸顯了對參考實驗室的需求。對分子診斷和基因組分析等先進檢測方法的需求不斷成長,推動了對能夠進行高精度檢測的專業參考實驗室的需求。
北美引領市場,佔據獸醫傳染病診斷市場最大佔有率
該報告還對所有主要區域市場進行了全面分析,包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告指出,北美是獸醫傳染病診斷最大的區域市場。
北美獸醫傳染病診斷市場的發展受到寵物和牲畜傳染病日益普及的推動。該地區犬瘟熱、貓白血病和各種人畜共通傳染病發病率的上升,凸顯了對有效診斷解決方案的需求。寵物主人對早期發現和預防疾病重要性的認知不斷提高,也推動了該地區市場的發展。北美的寵物主人對寵物健康的了解程度更高,也更加積極主動,這刺激了對先進診斷服務的需求。此外,獸醫診斷領域的技術進步日新月異,包括分子生物學、快速檢測方法和自動化分析儀的創新,正在支撐市場的成長。這些進步提高了診斷過程的準確性、速度和效率。此外,市場也受到對獸醫研發 (R&D) 日益成長的關注的推動,這得到了來自私營和公共部門的大量投資支持。
(請注意,這只是關鍵參與者的部分名單,完整名單將在報告中提供。)
The global veterinary infectious disease diagnostics market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. Increasing disease prevalence in pets and livestock, rising pet owner awareness, surging technological advancements, the need for accurate diagnostics, adoption of advanced tools, heightened pet health concerns, expanding veterinary infrastructure, government initiatives for zoonotic disease prevention, and enhanced research funding are factors fueling the market growth.
Growing Prevalence of Infectious Diseases in Pets and Livestock
Increasing prevalence of infectious diseases among pets and livestock is accelerating the market growth. For instance, feline leukemia virus (FeLV) is one of the most common infectious diseases in cats, affecting between 2-3% of felines in the US and Canada. The risk is further amplified by the surging interactions among pets and humans, which is further escalating the chances of disease transmission. Moreover, the rapid urbanization, changes in animal husbandry practices, and the rising number of diagnosed patients are supporting the market growth. Another factor boosting the veterinary infectious disease diagnostics market value is the burgeoning demand for accurate and timely diagnostics that can assist with efficient control and containment of these diseases.
Increasing Awareness Among Pet Owners
Rising awareness among pet owners about the importance of early disease detection is a crucial factor driving the market growth. With pets being considered integral family members, owners are increasingly prioritizing their health and well-being. This heightened awareness has led to a growing demand for regular health check-ups, preventive measures, and early diagnostic tests. Additionally, the availability of advanced diagnostic tools and technologies has made it easier for pet owners to access high-quality veterinary care, further driving the demand for infectious disease diagnostics.
Technological Advancements
According to the market overview, veterinary infectious disease diagnostics are witnessing considerably demand due to rapid technological advancements. Improvements in diagnostic have greatly improved the efficiency and accuracy of the results, which is further fueling the market growth. Furthermore, the introduction of molecular diagnostic technologies, such as polymerase chain reaction (PCR), designed to improve detection and identification in animal infectious diseases is facilitating the market growth. Apart from this, the incorporation of digital health tools, such as automated analyzers and telemedicine platforms, have simplified the diagnostics process, which is further supporting the market growth.
Immunodiagnostics accounts for the majority of the market share
According to the veterinary infectious disease diagnostics market research report, the immunodiagnostics segment holds the largest market share due to the increasing demand for accurate disease detection. Immunodiagnostic tests, including enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA), are essential for their ability to specifically detect antibodies or antigens related to infectious diseases. This precision is critical in identifying pathogens and diagnosing diseases at early stages, which is crucial for effective treatment and disease management. As veterinary care becomes more sophisticated, there is a growing expectation for highly reliable diagnostic tools that can provide definitive results quickly. The escalating prevalence of infectious diseases in pets and livestock has heightened the need for such accurate diagnostic solutions.
Companion animals holds the largest share of the industry
The companion animals segment in the veterinary infectious disease diagnostics market is driven by the focus on pet health and wellness, as well as advancements in diagnostic technology. Furthermore, the increasing prioritization of early disease detection by pet owners, who are more aware of the benefits of proactive health management are driving the market growth. This heightened awareness results in a growing demand for diagnostic services that can identify diseases before they become severe, leading to better health outcomes for pets. The segment is also driven by the availability of advanced diagnostic tools, such as molecular assays and rapid point-of-care tests, which offer accurate and timely results. These innovations enable veterinarians to diagnose and treat infections more effectively, enhancing the overall quality of care for companion animals.
Bacterial infections represent the leading market segment
The bacterial infections segment in the veterinary infectious disease diagnostics market is driven by the burgeoning prevalence of bacterial diseases among animals, which necessitates advanced diagnostic tools for effective management and control. The rising incidence of bacterial infections such as leptospirosis, tuberculosis, and salmonella in both pets and livestock fuels demand for precise diagnostic solutions. The growing awareness of the impact of bacterial diseases on animal health and productivity also drives the need for robust diagnostic methods to ensure early detection and intervention. Additionally, the segment is driven by the shifting focus on food safety, as bacterial infections in livestock can lead to contamination of the food supply, prompting stringent testing and monitoring requirements. The expansion of veterinary healthcare infrastructure and services, particularly in emerging economies, supports the growth of this segment by enhancing access to diagnostic technologies.
Reference laboratories dominates the market
The reference laboratories segment in the veterinary infectious disease diagnostics market is driven by the escalating complexity of diagnostic testing requirements. As veterinary diagnostics become more sophisticated, reference laboratories are increasingly relied upon for their advanced capabilities and specialized expertise. The segment is driven by the surging need for accurate and comprehensive diagnostic tests that can differentiate between various pathogens and diseases. This complexity necessitates the use of highly specialized equipment and skilled personnel, which are hallmarks of reference laboratories. Additionally, the segment benefits from the increasing volume of diagnostic samples that require thorough and high-resolution analysis, further underscoring the need for reference laboratories. The rising demand for advanced testing methods, such as molecular diagnostics and genomic analysis, drives the need for specialized reference laboratories capable of conducting these tests with high precision.
North America leads the market, accounting for the largest veterinary infectious disease diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for veterinary infectious disease diagnostics.
The North American veterinary infectious disease diagnostics market is driven by the growing prevalence of infectious diseases among pets and livestock. The rising incidence of diseases such as canine distemper, feline leukemia, and various zoonotic infections in the region underscores the need for effective diagnostic solutions. The regional market is also driven by the burgeoning awareness among pet owners about the importance of early detection and prevention of diseases. Pet owners in North America are more informed and proactive about their pets' health, which fuels demand for advanced diagnostic services. Moreover, the surging technological advancements in veterinary diagnostics, including innovations in molecular biology, rapid testing methods, and automated analyzers, are supporting the market growth. These advancements enhance the accuracy, speed, and efficiency of diagnostic processes. Apart from this, the market is driven by the escalating focus on veterinary research and development (R&D), supported by substantial investments from both private and public sectors.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)